The pharma industry has long relied on tried-and-true drug formulation approaches sometimes rooted in trial and error, but this reliance on the familiar has created a bottleneck in the development of new and better medicines. University of Toronto Professor Christine Allen, Ph.D., co-founder and CEO of Toronto-based Intrepid Labs, points out that the traditional drug…
Investments in AI and ML help PV teams transform safety case processing
Thanks to automation in pharmacovigilance, the next generation of safety is here — and with it, there is an immense opportunity for firms that can change how they work and maximize the opportunity automation creates. Leading safety teams are seeing up to 80% efficiency gains on key workflows by investing in touchless case processing, automating…
Digital transformation will give scientists their time back and speed the development pipeline
The pandemic exposed the innovation divide between the digitally transformed and those that lagged. Strict regulation made life sciences and bio/pharma organizations hesitant to modernize too quickly away from proven legacy methods and technologies, resulting in varying levels of digital transformation. But since the pandemic, organizations now recognize the necessity of digitalization and smart automation…